Home
Conditions
Thoracic Neoplasms

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,031 public trials 1,839 recruiting studies

Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Not Yet Recruiting

A Phase II Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics/Pharmacodynamics of JSKN033 in Patients With Advanced Non-Small Cell Lung Cancer

NCT07283198

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluation of AI-assisted LDCT Screening in Lung Cancer

NCT07280559

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Taipei Veterans General Hospital Taipei, Taiwan

View Trial Details

Not Yet Recruiting

The Percutaneous Interventional Surgery Control System for Pulmonary Nodule Biopsy

NCT07277088

Conditions: Disease, Lung Cancer (Diagnosis), Lung Diseases, +13 more
Locations: Shanghai Chest Hospital Shanghai, China

View Trial Details

Not Yet Recruiting

Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 Trial

NCT07274384

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes

NCT07272057

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

ADH1B and ALDH Gene Variants and Lung Cancer Risk

NCT07273279

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase 2 Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.

NCT07271602

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung Cancer

NCT06882174

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung Cancer

NCT07256509

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Minimal Residual Disease in Solid Malignancies

NCT07268469

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +30 more
Locations: Not specified

View Trial Details

Thoracic Neoplasms

Thoracic Neoplasms trial results

Related conditions